<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Acorda Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Acorda Therapeutics, Inc.

    Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2836
    • NIN CODE
      ####
    • LEADERSHIP
      Ron Cohen, MD
    • FOUNDED
      1995
    • EMPLOYEES
      251-500
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Concert Pharmaceuticals, Inc.

    Concert Pharmaceuticals, Inc.

    Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on a...

    Concert Pharmaceuticals is a clinical stage bio...

    Filing Type:    PU
    Neopenda, PBC

    Neopenda, PBC

    Neopenda is a medical device startup creating solutions that give patients in low-...

    Neopenda is a medical device startup creating s...

    Amount Raised:    $288,184.00
    Fundraising Status:    EC
    Filing Type:    CF
    Motus GI Holdings, Inc.

    Motus GI Holdings, Inc.

    Motus GI Holdings, Inc. is a medical technology company, with subsidiaries in the ...

    Motus GI Holdings, Inc. is a medical technology...

    Filing Type:    PU
    Karuna Therapeutics, Inc.

    Karuna Therapeutics, Inc.

    We are an innovative clinical-stage biopharmaceutical company primarily focused on...

    We are an innovative clinical-stage biopharmace...

    Filing Type:    PU
    Daiichi Sankyo Co., Ltd.

    Daiichi Sankyo Co., Ltd.

    Founded on September 28, 2005 through the merger of Daiichi Pharmaceutical and San...

    Founded on September 28, 2005 through the merge...

    Filing Type:    PU
    Sophiris Bio, Inc.

    Sophiris Bio, Inc.

    Sophiris Bio Inc. is a late-stage biopharmaceutical company developing topsalysin ...

    Sophiris Bio Inc. is a late-stage biopharmaceut...

    Filing Type:    PU
    Adamas Pharmaceuticals, Inc.

    Adamas Pharmaceuticals, Inc.

    Adamas Pharmaceuticals, Inc. is using its deep understanding of time-dependent bio...

    Adamas Pharmaceuticals, Inc. is using its deep ...

    Filing Type:    PU
    Axovant Gene Therapies Ltd.

    Axovant Gene Therapies Ltd.

    Axovant is accelerating the development of innovative gene therapy products that a...

    Axovant is accelerating the development of inno...

    Filing Type:    PU
    Assertio Therapeutics, Inc.

    Assertio Therapeutics, Inc.

    Assertio Therapeutics is committed to providing responsible solutions to advance p...

    Assertio Therapeutics is committed to providing...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.